Gut bacteria may predict immunotherapy success in bladder cancer
NCT ID NCT04566029
First seen Jan 05, 2026 · Last updated May 05, 2026 · Updated 15 times
Summary
This study explored whether the proteins from gut bacteria differ between bladder cancer patients who respond to immunotherapy and those who do not. Researchers collected stool and blood samples from 40 patients to compare these protein profiles. The goal was to find a way to predict which patients will benefit from treatment, avoiding unnecessary side effects and costs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Antoine Lacassagne
Nice, 06189, France
-
Centre Leon Berard
Lyon, 69373, France
-
HEGP GH Universitaire Paris Ouest
Paris, 75908, France
-
Hopital Tenon ( Paris)
Paris, Paris Cx 20, 75970, France
-
ICANS Strasbourg
Strasbourg, 67091, France
-
ICM parc euromedecine
Montpellier, Hérault, 34298, France
-
ICO-Site Paul Papin
Angers, 49055, France
-
Institut Bergonié
Bordeaux, 33076, France
-
Institut Sainte Cancerologie Lucien Neuwirth
Avignon, Saint Priest En Jarez, 42271, France
-
Iuct Oncopole
Toulouse, 31059, France
Conditions
Explore the condition pages connected to this study.